Browse by Day Archive
Ionis Pharma prices first FDA-approved treatment for Alexander disease at $285,000 per dose
09/03/2026 2:28pm
Ionis Pharmaceuticals said on Friday it would price its newly approved therapy to treat Alexander disease at $285,000 per dose, a day after the U.S. FDA cleared the injectable drug, making it the first approved treatment for the genetic disorder in adults and children.
Cyclosporiasis cases in Michigan climb to over 14,700, state health officials say
09/03/2026 12:32pm
Michigan health officials reported 14,718 cases linked to an outbreak of cyclosporiasis on Thursday, an increase of 208 cases since its last update a week earlier.
AbbVie's blood cancer therapy lowers disease progression, death risk in trial
09/03/2026 7:21am
AbbVie said on Thursday its therapy for a type of blood cancer has improved patients' response rate to treatment and reduced the risk of disease progression or death, meeting the main goals of a late-stage trial.
Aspen sees Mounjaro Africa sales above $124 million in 2027
09/03/2026 6:38am
Aspen Pharmacare expects African sales of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in its current financial year, buoyed by surging demand in South Africa and planned launches in Nigeria and Kenya.
Health officials turn to mobile-phone data to track Ebola spread in Congo
09/03/2026 5:24am
Health officials battling the Ebola outbreak in eastern Democratic Republic of Congo are using anonymised mobile-phone data to map population movements and identify areas where the virus could spread next, according to the World Health Organisation and researchers working with it.
Ultragenyx shares crater after Angelman syndrome drug fails late-stage trial
09/03/2026 4:31am
Shares of Ultragenyx Pharmaceutical plunged on Thursday after its neurodevelopmental disorder treatment failed a closely watched late-stage trial, dealing a major blow to one of its biggest growth bets.
Transgene jumps 20% on positive cancer vaccine data in early trial
09/03/2026 2:22am
Transgene shares surged 20% in early Paris trading on Thursday, after the French biotechnology company reported positive Phase 1 trial data on its vaccine candidate for head and neck cancer.
